A review of the global inequalities in the management of gynaecological cancers

Abstract

Key content The burden of gynaecological cancers is growing rapidly globally. Low‐resource countries are disproportionately affected with high rates of premature deaths from gynaecological cancers. This represents an epidemiological shift in these regions, which have historically been burdened with communicable diseases. Despite cervical cancer being a largely preventable disease, over 300,000 women die annually from the disease. Most of these deaths occur in low‐resource countries making this a disease of inequity. Initiatives such as the WHO cervical cancer elimination strategy demonstrates awareness of the problem, but considerable obstacles hinder attainment of their goals. Closing the gynaecological cancer care gap between high‐resource and low‐resource countries requires a multifaceted approach. Work must be done to increase public awareness of gynaecological cancers and dispel stigma and myths. Investment into healthcare infrastructure, workforce and research in low‐resource settings is needed, and strategies to reduce the negative impacts of poverty such as universal health coverage deserve consideration. Learning objectives To understand the global impact of gynaecological cancers. To understand the barriers to closing the gynaecological cancer gap between high‐resource and low‐resource countries. To understand how collaboration, research and implementation can be used to improve gynaecological cancer outcomes globally. Ethical issues Significant geographical disparities exist in gynaecological cancer outcomes, with the majority of deaths occurring in low‐resource countries. Addressing this disparity requires a multifaceted approach that thoughtfully examines all contributing factors and offers practical, actionable solutions.